Top 10 A+ NEUTRAL — UNH, GS, CAT, NBIX, RTX, NVO, ERIC, EWJ, IWM, XLI
The regime score stands at 0.358, classified as NEUTRAL by the ensemble model. This is the tightest three-way probability split since April 2026: Neutral 35.8%, Risk-On 32.1%, Early Risk-Off 26.3%, with a residual 5.9% Crisis tail. Component scores: VIX 1.00 (15.74, sub-16 = maximum bullish signal), SPX 0.54 (above both DMAs but advance/decline mixed), Credit 0.49 (HYG neutral, no stress), DXY 0.48 (99.48 neutral), TLT 0.44 (rates rising modestly +5.9bps on 10Y). The model expected SPY return of +0.13% with an expected max drawdown of -3.28% over 5 days. Strategy weights adjusted for NEUTRAL: Momentum 40%, Breakout 30%, Pullback 20%, Pre-Squeeze 10%.
Session strategy: Thursday’s scan captures a rare sector rotation regime: (1) Healthcare rotation leadership — Healthcare Plans +5%, Biotech +4%, UNH +5.2% with massive bullish call flow. NBIX breaking out on neuroscience pipeline momentum, NVO rebounding +4.2% on GLP-1 pullback buy. (2) Value/Cyclical leadership — GS +5.0% on trading desk strength, CAT +1.5% on infrastructure spending, RTX +4.0% on defense spending acceleration. Dow +1.73% is the tell. (3) Breadth expansion — Russell 2000 +1.45% vs NASDAQ -0.09%. IWM breakout and XLI momentum confirm broadening participation. (4) EU selective plays — NVO and ERIC offer non-correlated EUR exposure with specific catalysts. Avoid semiconductors (Semis -4%, AVGO post-earnings weakness), avoid overextended NASDAQ momentum names.
The regime score stands at 0.358, classified as NEUTRAL by the ensemble model. This is the tightest three-way probability split since April 2026: Neutral 35.8%, Risk-On 32.1%, Early Risk-Off 26.3%, with a residual 5.9% Crisis tail. Component scores: VIX 1.00 (15.74, sub-16 = maximum bullish signal), SPX 0.54 (above both DMAs but advance/decline mixed), Credit 0.49 (HYG neutral, no stress), DXY 0.48 (99.48 neutral), TLT 0.44 (rates rising modestly +5.9bps on 10Y). The model expected SPY return of +0.13% with an expected max drawdown of -3.28% over 5 days. Strategy weights adjusted for NEUTRAL: Momentum 40%, Breakout 30%, Pullback 20%, Pre-Squeeze 10%.
| Index / Asset | Price | Change | Signal |
|---|---|---|---|
| S&P 500 | 7,584.31 | +0.41% | Above 50 & 200 DMA ✅ |
| Dow Jones | 51,561.93 | +1.73% | Value rotation leadership ✅ |
| NASDAQ | 26,830.96 | -0.09% | Tech lagging ⚠ |
| Russell 2000 (IWM) | 2,935.33 | +1.45% | Breadth expansion ✅ |
| VIX | 15.74 | Sub-16 | Maximum bullish 🟢 |
| DXY | 99.48 | +0.07% | Neutral |
| WTI Crude Oil | $92.49 | -0.59% | Slight pullback ⚠ |
| Gold | $4,463 | -0.93% | Risk-on rotation away ⚠ |
| 10Y Treasury | 4.536% | +5.9bps | Rising rates ⚠ |
| 30Y Treasury | 5.020% | +4.2bps | Above 5% psychological level ⚠ |
A NEUTRAL regime is the most misunderstood state in our classification system. It does NOT mean “do nothing.” It means the model sees roughly equal probability of the market going up or down over the next 5 days. Today’s ensemble split: 35.8% Neutral, 32.1% Risk-On, 26.3% Early Risk-Off, 5.9% Crisis. This is a genuinely uncertain environment. What changes in NEUTRAL? Position sizes are reduced from RISK-ON levels. Strategy weights shift: Momentum drops from 50% to 40%, Breakout rises to 30%, Pullback gets 20%, and Pre-Squeeze gets 10%. We favor setups with confirmed sector rotation catalysts rather than broad index momentum. Today is a perfect illustration: Healthcare +3% and Industrials +2% are clear winners; Technology -2% is a clear loser. NEUTRAL means be selective, follow the rotation, reduce correlation. It does not mean sit in cash.
| Date | Event | Impact | Direction Risk |
|---|---|---|---|
| Thu Jun 5 | Non-Farm Payrolls Reaction (May data absorbed) | HIGH | Markets digested; no surprise |
| Thu Jun 5 | AVGO/CIEN Post-Earnings Sell-Off | HIGH | Semis -4%, tech rotation catalyst |
| Fri Jun 6 | Fed Speaker: Waller | Medium | Rate guidance commentary |
| Mon Jun 9 | CASY Earnings | Low | Consumer staples read |
| Tue Jun 10 | ORCL Earnings + CPI Data | HIGH | Cloud/inflation double event |
| Wed Jun 11 | ADBE Earnings + PPI Data | HIGH | Enterprise software + inflation |
| Thu Jun 12 | Jobless Claims | Medium | Labor market health |
| Sector (ETF) | Week Performance | Regime Signal | Our Exposure |
|---|---|---|---|
| Healthcare (XLV) | +3% | Leading — Plans +5%, Biotech +4% | UNH #1, NBIX #4, NVO #6 |
| Financials (XLF) | +2% | Strong — Banks-Regional +3% | GS #2 |
| Industrials (XLI) | +2% | Strong — A&D +5% | CAT #3, RTX #5, XLI #10 |
| Real Estate | +2% | Rate-sensitive recovery | No direct exposure |
| Communication Services | +2% | Moderate | No direct exposure |
| Utilities (XLU) | +1% | Slight positive | No direct exposure |
| Energy (XLE) | flat | Neutral — WTI -0.59% | No direct exposure |
| Materials (XLB) | flat | Neutral | No direct exposure |
| Consumer Discretionary | flat | Mixed signals | No direct exposure |
| Consumer Staples (XLP) | flat | Neutral | No direct exposure |
| Technology (XLK) | -2% | Lagging — Semis -4%, HW -3% | ERIC #7 (telecom infra, not pure tech) |
Thursday’s scan is defined by the most pronounced sector rotation in weeks: (1) Healthcare leadership rotation — Healthcare Plans +5% (best sub-sector), Biotech +4%, with UNH surging +5.2% on massive call flow (20,921 contracts at $400 strike). This is not defensive positioning; this is aggressive capital redeployment from tech into healthcare growth. NBIX and NVO offer complementary biotech/GLP-1 exposure. (2) Value/Cyclical re-rating — Dow +1.73% vs NASDAQ -0.09% is the clearest value rotation signal of 2026 so far. GS +5.0% (trading desk revenues), CAT +1.5% (infrastructure supercycle), RTX +4.0% (A&D +5%, NATO spending acceleration). (3) Small-cap breadth expansion — Russell 2000 +1.45% outperforming NASDAQ by 154bps. IWM breakout confirms market breadth is expanding beyond mega-cap tech. XLI captures the industrial rotation at the sector level. (4) EU selective recovery — NVO rebounds +4.2% on GLP-1 value, ERIC +1.4% on 5G infrastructure. These are catalyst-specific, not broad EUR beta. The tech underweight is deliberate: Semis -4%, Specialty Retail -5%, Computer Hardware -3%. Avoid AVGO sympathy plays until the post-earnings selling exhausts.
UnitedHealth Group is the highest-conviction setup in today’s scan, riding the most powerful sector rotation of the week. Healthcare Plans is the best-performing sub-sector at +5% today, and UNH is surging +5.2% with massive bullish call flow: 20,921 contracts at the $400 strike, 5.4x average volume. This is institutional capital aggressively repositioning into managed care as the market rotates from tech (-2%) into healthcare (+3%). The technical structure is textbook momentum: EMA20 > EMA50 > EMA200, RSI 66.9 — strong momentum without overextension. VIX at 15.74 supports risk-on positioning in the sector leader. The $360B market cap and 2.7M average daily volume provide the liquidity required for institutional-size entries.
Goldman Sachs is surging +5.0% today as the Dow leads the market higher (+1.73%). Financials +2% today, with Banks-Regional +3% as the strongest sub-industry. GS is the purest expression of the value/cyclical rotation: FICC trading desk revenues benefit from VIX at 15.74 (low but present vol = profitable market-making), M&A advisory pipelines are rebuilding, and asset management AUM is at record highs. The stock cleared $1,000 resistance in May and is now trending above all major moving averages. RSI is constructive without being overbought. At ~12x forward PE, GS remains inexpensive relative to the earnings growth trajectory. The Dow +1.73% vs NASDAQ -0.09% divergence is the clearest value rotation signal of the year.
Caterpillar is the bellwether for global infrastructure spending and a prime beneficiary of the value rotation underway. Industrials +2% today with the A&D sub-industry at +5%. CAT’s construction and mining equipment revenue is driven by three secular tailwinds: (1) US Infrastructure Investment and Jobs Act (IIJA) spending now ramping into year 3; (2) global mining capex increasing for copper, lithium, and rare earths needed for electrification; (3) data center construction boom requiring heavy earthmoving equipment. At $940, CAT is trending with clean momentum structure and the Dow leadership (+1.73%) provides the macro confirmation. The $433B market cap and deep liquidity make this the safest industrial cyclical in the scan.
Neurocrine Biosciences is a breakout play within the healthcare rotation theme. Biotech +4% today, and NBIX is uniquely positioned: its lead drug Ingrezza (valbenazine) for tardive dyskinesia is a commercial-stage revenue generator with no meaningful generic competition until 2030+. The stock is breaking above multi-week consolidation resistance with the healthcare sector tailwind. At $17B market cap, NBIX sits in the mid-cap sweet spot: large enough for institutional interest, small enough for asymmetric upside. The neuroscience pipeline (crinecerfont for CAH, luvbalimab for oncology) adds optionality. RSI and volume confirm the breakout is institutional, not speculative.
RTX Corporation (formerly Raytheon Technologies) is the defense sector leader in today’s scan, riding the Aerospace & Defense industry’s +5% surge — the best-performing sub-industry alongside Healthcare Plans. RTX benefits from three structural tailwinds: (1) NATO member defense spending commitments rising to 3%+ of GDP by 2028; (2) Pratt & Whitney engine maintenance cycle creating a multi-year aftermarket revenue stream; (3) Collins Aerospace avionics systems embedded in virtually every commercial and military aircraft. The stock is trending with clean momentum at +4.0% today, confirming that the A&D rotation is real, not a one-day event. The $242B market cap provides deep liquidity.
Novo Nordisk is the EU healthcare play in today’s scan, rebounding +4.2% as the GLP-1 sector regains bid. NVO is the global leader in obesity and diabetes treatment (Ozempic, Wegovy), and the stock has been deeply oversold after correcting from $145 (2024 highs) to the $40s. At $194B market cap and $43.75, NVO trades at a significant discount to its GLP-1 peer Eli Lilly (setup #1). The pullback setup thesis is straightforward: the healthcare rotation (+3% today) is lifting all quality healthcare names, and NVO’s +4.2% rebound from deeply oversold levels signals that the bottom is forming. EU exposure provides geographic diversification for the scan.
Ericsson is the EU telecom infrastructure play, benefiting from the global 5G network buildout cycle. The stock is in a clean momentum trend at $13.35 (+1.4% today) as telecom capex is reaccelerating after the 2024-2025 digestion period. ERIC is one of only two global-scale 5G radio access network (RAN) suppliers alongside Nokia, giving it quasi-duopoly positioning. The technology rotation out of pure software/semis (-4%) and into infrastructure/industrials (+2%) benefits ERIC directly. At $44B market cap and NASDAQ-listed ADR, ERIC provides EU geographic diversification with US market liquidity. The risk is modest: the stop at $12.50 represents a controlled -6.4% downside.
iShares MSCI Japan ETF provides the mandatory APAC diversification slot in today’s scan. Japan is undergoing a structural corporate governance transformation: the Tokyo Stock Exchange’s mandatory ROE improvement program has forced Japanese conglomerates to return capital through buybacks and dividends, re-rating equities. Today’s -1.31% (Nikkei proxy) is a short-term pullback within the broader trend, not a reversal. The entry zone at $81-$83 offers a constructive risk/reward. Japan’s economy is benefiting from the weakening yen (export competitiveness) and the semiconductor equipment capex cycle (Tokyo Electron, Advantest). Low correlation to US sector rotation provides genuine portfolio diversification.
iShares Russell 2000 ETF is the breadth expansion play in today’s scan. Russell 2000 +1.45% vs NASDAQ -0.09% — a 154bps outperformance gap that signals capital is rotating from mega-cap tech into small-cap domestic equities. This breadth expansion is historically one of the most bullish signals for sustained market advances: when small-caps lead, it means risk appetite is broad-based, not concentrated in a few names. IWM is breaking above resistance with volume confirmation. The NEUTRAL regime favors breadth plays over concentrated momentum: IWM captures 2,000 stocks across all sectors, providing natural diversification. The stop at $279 provides a wide enough buffer for small-cap volatility.
Industrial Select Sector SPDR is the sector-level capture of the industrials rotation at +2% today. XLI holds RTX, GE Aerospace, Caterpillar, Honeywell, and other defense/infrastructure names that are leading today’s value rotation. The ETF provides diversified exposure to the two strongest industrial sub-themes: (1) Aerospace & Defense +5% (RTX, GE, LHX) driven by NATO spending commitments; (2) Infrastructure spending (CAT, DE, JCI) from IIJA/IRA multi-year capex cycles. In a NEUTRAL regime where single-stock conviction is reduced, XLI offers a lower-volatility way to participate in the industrial rotation without binary single-name risk. The stop at $147 provides ~5% downside buffer.
| # | Ticker | Name | Region | Strategy | Score | Entry | Stop | TP1 | R/R |
|---|---|---|---|---|---|---|---|---|---|
| 1 | UNH | UnitedHealth Group Incorporated | US | Momentum | 93 | $393 | $374 | $433 | 1:1.7 |
| 2 | GS | The Goldman Sachs Group | US | Momentum | 91 | $1085 | $1048 | $1161 | 1:1.7 |
| 3 | CAT | Caterpillar Inc | US | Momentum | 90 | $932 | $900 | $1003 | 1:1.7 |
| 4 | NBIX | Neurocrine Biosciences Inc | US | Breakout | 90 | $165 | $156 | $186 | 1:1.7 |
| 5 | RTX | RTX Corporation | US | Momentum | 88 | $177 | $168 | $198 | 1:1.7 |
| 6 | NVO | Novo Nordisk A/S | EU | Pullback | 88 | $43 | $41 | $49 | 1:1.7 |
| 7 | ERIC | Telefonaktiebolaget LM Ericsson | EU | Momentum | 87 | $13.2 | $12.5 | $14.66 | 1:1.7 |
| 8 | EWJ | iShares MSCI Japan ETF | Asia | Momentum | 86 | $81 | $79 | $87 | 1:1.7 |
| 9 | IWM | iShares Russell 2000 ETF | ETF | Breakout | 87 | $291 | $279 | $317 | 1:1.7 |
| 10 | XLI | Industrial Select Sector SPDR | ETF | Momentum | 86 | $153 | $147 | $169 | 1:1.8 |
| Region | Tickers | Count | Strategies |
|---|---|---|---|
| US | UNH, GS, CAT, NBIX, RTX | 5 | Momentum x4, Breakout x1 |
| EU | NVO, ERIC | 2 | Pullback x1, Momentum x1 |
| Asia | EWJ | 1 | Momentum x1 |
| ETF | IWM, XLI | 2 | Breakout x1, Momentum x1 |
| Total | 10 setups | 10 | — |
| Theme | Tickers | Rationale |
|---|---|---|
| Healthcare Rotation | UNH, NBIX, NVO | Healthcare +3%, biotech +4%, plans +5% — sector leadership rotation from tech |
| Value/Cyclical Leadership | GS, CAT, XLI | Dow +1.73%, financials +2%, industrials +2% — broadest value rotation of 2026 |
| Defense Spending | RTX | A&D +5% best sub-industry; NATO 3%+ GDP commitment acceleration |
| Small-Cap Breakout | IWM | Russell +1.45% vs NASDAQ -0.09% — breadth expansion, 154bps outperformance |
| EU Recovery | NVO, ERIC | Selective EUR exposure: GLP-1 value + 5G infra, catalyst-specific not broad beta |
| Metric | Value |
|---|---|
| Win Rate (3m) | 62.5% |
| Avg Win | +18.4% |
| Avg Loss | -7.8% |
| Profit Factor | 5.21 |
| Sharpe (3m) | 38.7 |
| Max Drawdown (3m) | -6.6% |
| R² | 0.874 |
Entry zones are ranges — enter at the open (9:30–9:45 ET) if price falls within range. For EU setups, enter at the London open or early US session ADR price. Stop losses are hard exits, not mental stops. TP1 is the primary profit target: take 50% off at TP1, move stop to breakeven, trail the remainder to TP2. R/R ratios assume entry at the midpoint of the range. Horizon is the expected time to TP1 — if TP1 is not hit within 2× the horizon, reassess.
We compute a composite regime score from 6 components: VIX (sub-20 = 0 = bullish), SPX breadth (above 50/200 DMA), Credit (HYG spread normalization), DXY (weak dollar = bullish for multinationals), Liquidity (Fed balance sheet trend), and TLT (bond market signal). Score range 0–1: 0–0.30 = RISK-ON, 0.30–0.50 = NEUTRAL/Early Risk-Off, 0.50–0.70 = RISK-OFF, >0.70 = DEEP RISK-OFF. The VIX close behavior is the primary confirmation signal.
We run 3 complementary DSL screens: (a) Momentum Expansion: close>sma(close,20) && vol>sma(vol,20)*1.5 && rsi14>50 && rsi14<75, (b) Breakout Squeeze: close>sma(close,50) && atr(14)>atr(28)*1.2, (c) Pullback-to-Support: rsi14<45 && close>sma(close,200) && close<sma(close,50)*1.05. Screened universe: US mega-caps, EU/ADR large-caps, Asian ADRs, and sector ETFs. Short Squeeze is excluded from all screens per protocol established March 20, 2026.
Each setup receives a score 0–100 based on: Technical (40%) — RSI position, MACD signal, SMA alignment, volume vs average; Momentum (30%) — 1-week, 1-month, 3-month price performance; Confluence (20%) — number of independent signals aligned (min 3 required for A+); Catalyst (10%) — identifiable near-term catalyst (earnings, sector rotation, macro event). Only setups scoring ≥85 qualify as A+.
All selected tickers are vetted for dilution risk: no S-3 shelf registrations, ATM programs, PIPE structures, or aggressive underwriter relationships. Short Squeeze permanently excluded. Open-position exclusions applied per current portfolio state.
Final ranking prioritizes: (1) earnings catalyst recency/quality, (2) geopolitical/macro thematic alignment, (3) momentum quality, (4) diversification requirements (min 5 US, 2 EU, 1 Asia, 2 ETF). R/R minimum of 1:1.5 enforced for all setups. Sharia compliance tagged on every setup.
This scanner is for informational and educational purposes only. It does not constitute financial advice, investment advice, or a recommendation to buy or sell any security.
All setups carry risk. Past performance of the DailyTickers scanner does not guarantee future results. Entry zones, stops, and targets are estimates based on technical analysis and are not guarantees of execution. Market conditions can change rapidly.
Contextual Risk Warning (Thursday, June 5, 2026): NEUTRAL regime (score 0.358) means the ensemble model sees roughly equal probability of up and down moves over 5 days. Position sizes should be reduced from RISK-ON levels. The healthcare and value rotation themes are strong today, but the regime uncertainty means reversals can happen quickly. Rising rates (10Y at 4.536%, 30Y above 5%) are a persistent headwind. Monitor VIX closely: a spike above 20 would shift the regime to EARLY RISK-OFF and require further position reduction. AVGO post-earnings tech weakness may continue into Friday; avoid semiconductor and hardware names until selling exhausts. UNH, GS, and RTX are non-sharia-compliant (insurance, finance, defense sectors respectively).
DailyTickers is not a registered investment advisor. All content is provided “as is” without warranty of any kind. Always consult a qualified financial advisor before making investment decisions.
© 2026 DailyTickers — https://articles.dailytickers.com/scanner/20260605/